Abstract
Background Sick sinus syndrome comprises a variety of conditions involving sinus node dysfunction and commonly affects elderly persons. When patients have contraindications or refuse to receive pacemaker therapy, the alternative treatment could be considered. Case Description A 36-year-old male of sick sinus syndrome successfully treated with Traditional Chinese Medicine (TCM) was reported. This patient refused permanent pacemaker implantation for personal reasons. Traditional Chinese Medicine, Sumailing Koufuye, was employed. After 1-day administration, the patients recovered significantly, both in manifestations and Holter Holter monitor. Conclusion TCM showed therapeutic effects for early stage of sick sinus syndrome and could be promising alternative treatment.
References
Dobrzynski H, Boyett MR, Anderson RH. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation. 2007;115(14):1921–32.
Adan V, Crown LA. Diagnosis and treatment of sick sinus syndrome. Am Fam Phys. 2003;67(8):1725–32.
D’Alessandro A, Boeckelmann I, Hammwhoner M, Goette A. Nicotine, cigarette smoking and cardiac arrhythmia: an overview. Eur J Cardiovasc Prev Rehabil. 2011. doi:10.1177/1741826711411738.
Liu JFLR, Liu ZM. Comparative observation on clinical therapeutic efficacy of Chinese herbal medicine and Western medicine on sick sinus syndrome. Zhongguo Zhongyiyao Xinxi Zazhi. 2008;15(4):15–7.
Zhang JL. Advances in the treatment of sick sinus syndrome with traditional Chinese medicine. Zhong Xi Yi Jie He Za Zhi. 1987;7(11):699–701.
Han MX. A survey of traditional Chinese medicine in the sick sinus syndrome. Zhong Xi Yi Jie He Za Zhi. 1986;6(6):376–9.
Funding
This study was supported by the National Science Foundation of China (No. 81001659).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, CJ., Fan, G. & Zhang, BL. Successful treatment of sick sinus syndrome with Traditional Chinese Medicine. Int J Clin Pharm 34, 515–517 (2012). https://doi.org/10.1007/s11096-012-9649-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-012-9649-8